Literature DB >> 15920529

From signatures to models: understanding cancer using microarrays.

Eran Segal1, Nir Friedman, Naftali Kaminski, Aviv Regev, Daphne Koller.   

Abstract

Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis is essential to transform the masses of generated data into a mechanistic understanding of disease. Here we review current research aimed at uncovering the modular organization and function of transcriptional networks and responses in cancer. We first describe how methods that analyze biological processes in terms of higher-level modules can identify robust signatures of disease mechanisms. We then discuss methods that aim to identify the regulatory mechanisms underlying these modules and processes. Finally, we show how comparative analysis, combining human data with model organisms, can lead to more robust findings. We conclude by discussing the challenges of generalizing these methods from cells to tissues and the opportunities they offer to improve cancer diagnosis and management.

Entities:  

Mesh:

Year:  2005        PMID: 15920529     DOI: 10.1038/ng1561

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  138 in total

Review 1.  Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

Authors:  Naftali Kaminski; Ivan O Rosas
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 2.  Towards systems biology of human pulmonary fibrosis.

Authors:  Sean M Studer; Naftali Kaminski
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 3.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

Review 4.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

5.  DEGAS: de novo discovery of dysregulated pathways in human diseases.

Authors:  Igor Ulitsky; Akshay Krishnamurthy; Richard M Karp; Ron Shamir
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

6.  Integrating biological knowledge with gene expression profiles for survival prediction of cancer.

Authors:  Xi Chen; Lily Wang
Journal:  J Comput Biol       Date:  2009-02       Impact factor: 1.479

7.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Kazuhisa Konishi; Kevin F Gibson; Kathleen O Lindell; Thomas J Richards; Yingze Zhang; Rajiv Dhir; Michelle Bisceglia; Sebastien Gilbert; Samuel A Yousem; Jin Woo Song; Dong Soon Kim; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2009-04-10       Impact factor: 21.405

8.  Significance analysis of spectral count data in label-free shotgun proteomics.

Authors:  Hyungwon Choi; Damian Fermin; Alexey I Nesvizhskii
Journal:  Mol Cell Proteomics       Date:  2008-07-20       Impact factor: 5.911

9.  A scaling-free minimum enclosing ball method to detect differentially expressed genes for RNA-seq data.

Authors:  Yan Zhou; Bin Yang; Junhui Wang; Jiadi Zhu; Guoliang Tian
Journal:  BMC Genomics       Date:  2021-06-26       Impact factor: 3.969

10.  A SPARSE CONDITIONAL GAUSSIAN GRAPHICAL MODEL FOR ANALYSIS OF GENETICAL GENOMICS DATA.

Authors:  Jianxin Yin; Hongzhe Li
Journal:  Ann Appl Stat       Date:  2011-12       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.